Podcasts about vha

For many people, the FDA-approved drug class called GLP-1s has been a game changer for managing type 2 diabetes and weight loss. An estimated one in eight US adults is using this type of drug, which mimics a natural gut hormone to regulate blood sugar, slow stomach emptying, and suppress appetite. Researchers and the public have been scrutinizing the pros and cons of taking these drugs for many years. One critical question that remains is does the use of GLP-1s translate into lower medical expenses for consumers, healthcare providers, insurance companies, and the government? Today, we're speaking with Duke University health economist Jonathan Zhang on the answer to these questions from his multi-year study of veterans who use GLP-1s. The results are surprising. Interview Summary Jonathan, first, let's talk broadly. Would you briefly describe the kinds of health benefits people are experiencing with GLP-1s, particularly in terms of changes in behavior and overall health? Yes. So GLP-1s are medications that manage body weight and improve metabolic health. The primary health benefits are via better blood sugar regulation and weight loss via reducing appetite. But there's larger health benefits that are much broader. So, trials have also shown that they lower blood pressure, reduce strokes and heart attacks, among other cardiovascular benefits. Overall also improves, so things like obstructive sleep apnea, improvements in inflammation-related measures. And recently it was FDA approved to treat MASH, which is a form of fatty liver disease. Finally, people also report feeling less hungry. They get full faster, fewer cravings, and reduction in what is often called food noise, which can potentially help people make a range of better behavior decisions and changes relating to food and perhaps even beyond food. However, the evidence on that seems to be promising, but new and less strong. Thank you for sharing those. I know a lot of our listeners have heard some of those issues and some of those points about how GLP-1s could change the way we behave, and some of the health outcomes. So, let's dig into your particular study. In your working paper for the National Bureau of Economic Research (NBER) you and your co-authors describe a natural experiment involving patients and doctors in the Department of Veteran Affairs, and their access to and use of GLP-1s. Would you lay out the general parameters of your study for our listeners? Yes, absolutely. So, like many medications, what we know about GLP-1s primarily comes from randomized controlled trials, which have small sample sizes and often select for quite sick patients. As GLP-1s reach a broader population, the population becomes less pro-comparable to those in trials, so the real-world impacts become less obvious. Moreover, there are some outcomes such as healthcare utilization or spending costs that are incredibly important for policy but not directly studied in trials. We were interested in studying in a very large healthcare system, that is the VA, the Veterans Health Administration, the real-world impacts of GLP-1s using readily collected data from the healthcare system and a quasi-experiment. So that is we try to emulate a real experiment where some patients get GLP-1s from their primary care doctor and others do not. And the reason one patient might get it while the other doesn't is because their doctors differ in their likelihood or propensity to prescribe these drugs. And we focus on the Veterans Health Administration, the VHA, because the veteran population is quite diverse, at least in terms of comorbidities relative to the trials per se and also in age, say, compared to Medicare. And GLP-1s are provided in the VA to eligible patients at a pretty affordable cost. So, sort of a nice policy playground for us to think about what outcomes might look like when GLP-1s become readily available and affordable to all Americans. Great. Thank you for sharing that because now we have a good sense of the quasi experiment that you all were able to exploit. That there were providers who had a high tendency to prescribe GLP-1s versus those who didn't. And looking at that difference, you were able to see how GLP-1s may have affected the outcomes that you were interested in. So now tell us a bit about the findings, and I think there's some surprising results here. So, first we replicate many of the findings from the randomized trials for this diverse, veteran population. We see reductions in body weight, we see hemoglobin A1C blood glucose levels improve and blood pressure improvements as well. Even a reduction in heart attacks and strokes for patients with existing cardiovascular conditions, and even a small reduction in moderate drinking risk as well. The trial evidence seems to hold up in this large and diverse population of we have 1.4 million patients that we're studying. Second, despite these improvements though, we do not see a reduction in healthcare spending. This is actually excluding the cost of the medication, the GLP-1. It's not because GLP-1s are expensive. We're taking that out of the equation. Over four years, this is how long we're able to track these patients for, we're able to rule out reductions of more than 7% in healthcare spending. And we see no reductions in whether that's outpatient clinic or in inpatient hospitalization. We also don't see any reductions in emergency department visits more generally, despite seeing a reduction in heart attack and strokes for those patients with existing cardiovascular condition. Jonathan, that sounds great, but it's a little hard to understand. So why is it that you're seeing no real changes in the consumer healthcare spending? What's going on? Yes, we were a little surprised as well. We think there could be a myriad of potential reasons. But first, I want to note that there's also at least three other studies that use real-world data to look at a similar question, and all the studies find no statistically significant spending reductions. And in fact, all of us, we all find a slight positive increase. I think the first explanation is that while heart attacks and strokes are very expensive and obviously, very serious events, they are still thankfully quite rare and thus are not very common in our three to five-year period in which these studies are looking at. But perhaps over ten or twenty years, you could start seeing some healthcare spending materialize. I think that's totally possible. Most cost projection models, whether that's from the CBO or other organizations, they project healthcare spending reductions to accumulate over time. But these models also project immediate spending reduction, which is not yet supported by the data. Another potential explanation is what I would call these behavioral responses. So, you can imagine that a patient sees some improvement in their health, and that changes their expectation of, "Oh, wow, I could actually make some changes to my health." And they actually go and get some more care. This can also be driven by the physician as well. So, sort of, "Look, things are working. This patient's seeing improvements. Maybe we should treat some of your other health problems and issues." This is what I would call sort of a behavioral response. A third explanation could be that some of these patients have conditions that have progressed to be irreversible even with metabolic health gains. So, for example, late-stage kidney disease would be a good example. We find some suggestive evidence that this might be happening in our study. In other words, for these patients where they have some potentially irreversible health conditions, the metabolic health improvements - that's not a primary reason for their healthcare spending. This is helpful. That explains why we're seeing some of these challenges with healthcare spending. And I appreciate your point of taking a longer view may actually reveal some differences. And also, the responses of doctors and patients to the benefits that they gain and how that might expand opportunities for healthcare. So, thank you for sharing that. I want to shift focus a little bit. And it is taking a step beyond the paper, but I think it's a natural extension of the work. As you know, I'm an agricultural economist, and I've been interested in obviously food policy issues. And the fact that we're seeing weight loss, the fact that we're seeing better management of A1C suggests that there's something probably happening with food consumption and food patterns. I'd be interested to learn from you if you have any ideas about what this work suggests about the impact of GLP-1s on consumer food choices. Yes, I think there's a fair amount of both trial and real-world grocery purchase evidence that GLP-1s are impacting consumer food choices. In the randomized trials, GLP-1s reduce, calories consumed, reduce the desire to eat sweet, salty, and savory foods and high fat fast foods in their meals. For example, these trials will look at what people eat for lunch. In real world data, there's a study out of Denmark that found that after patients' first GLP-1 prescription, their grocery store purchases went on to have fewer calories, sugars, saturated fats, carbohydrates, and more protein over the one-year period after they initiate GLP-1s. The share of ultra-processed foods also decreased. The effects were actually quite modest, so there was only about a one percent reduction in calories and a four percent reduction in sugar and a five percent increase in protein in the year after versus the year before in this Danish study. In the US, there's a similar study using kind of this transactional level data as well. And they find that households after they start GLP-1s also reduce caloric intake, fast food consumption, caloric dense processed foods. And there it's a little larger in the US by about five to ten percent. Then the question is, you know, are they shifting towards healthier foods or is it sort of a uniform reduction in calories across all different food classes? And there the evidence is a little less strong. There's some evidence that consumers are shifting towards healthier foods, but if that is the case, the shift is quite small. In both the Danish and the US study, it's roughly looking like a level shift for all different categories. And this is also in terms of not food so much anymore, but there's also been studies looking at alcohol consumption, which has been very interesting and promising. There's a phase two study pilot trial with only forty-eight participants, but the randomized control trial found that among patients with existing alcohol use disorder GLP-1s led to a reduction in the average number of drinks per day. No change in the number of days drinking, but conditional on drinking, the average number of drinks per day declines in the treatment group that get GLP-1s. And then for out of the 48 patients that are also smokers, there's also a reduction in smoking as well in that population. So, very promising early evidence there as well. Jonathan, this is critical information, and I know some colleagues in the Ag econ profession, folks like Brian Roe, Tim Richards and Glenn Townsend have also worked in this space, and some of the work is showing some issues around the quality of protein or overall food spend is going down. And the choices or the responsiveness of people to prices when it comes to proteins. There's some evidence, some causal evidence to suggest GLP-1s are changing the way people are even looking at food markets. And so that raises a really important issue. If consumers are changing when they're exposed to GLP-1s, I have got to imagine that the food industry, grocery stores, food manufacturers, restaurants are making some adjustments. What have you to say on that particular point? So, we're both economists, right? We both, of course, believe that producers and grocery stores are adjusting to demand. We do know a lot less about how the supply side is adjusting compared to the demand, and that's because there's just less data and fewer studies on patients. There's more data and more studies on patients and consumers than on grocery stores and restaurants. I've seen a lot of anecdotal evidence, often reported in the mainstream media or reports from various market research agencies that GLP-1s are having this large impact on the food industry. I've seen claims like GLP-1s are hurting Walmart sales or why are beer company sales down, like AB InBev, and range into things like why restaurants are reducing their portions or recently I actually also saw over the past couple weekends claims of why Coachella portions are smaller because everyone's on GLP-1s. So, the best estimates from last year are that one in eight Americans are using GLP-1s. And if each of these users are cutting back in consumption by 5% to 10%, as in those studies, it's totally plausible this leads to a large population reduction that the food industry just cannot ignore, right? I think it's important to note a couple things. First is that the long-term adherence of GLP-1s is generally quite low, with more than 50% discontinuing within a year in most of the studies I've seen in the US. And after discontinuation, most of these patients will gain back a large fraction of their weight. And in that US groceries transactional study I told you about, they find that after discontinuation, purchases at fast food, grocery, restaurants, et cetera, they go up beyond baseline, in fact. So, beyond six months prior to when they were on GLP-1s. It's still an open question to whether these 5% to 10% individual consumption reductions will become long-term and manifest in the population level, especially if adherence is not very high. Second is that up until very recently, there's been a very strong demographic and socioeconomic profile of these GLP-1 users, right? So, they tend to skew near elderly and also a little bit more female, and generally fall in the middle- or higher-income brackets because previously Medicaid, for example, did not cover GLP-1s, right? Until earlier this year. And it still does not cover it for many states. So, any food industry changes will likely be concentrated in the restaurants and the food chains that sort of have these consumer demographic and economic base. That's something to keep in mind. Certainly, there are examples like, you know, Smoothie King has introduced a GLP-1 smoothie. But even in these clear-cut cases where the producer is clearly trying to appeal to this demand shock, it's still very difficult to disentangle the producer's stated intent from general industry market trends, right? So, general trends like rising cost of living. There's been more demand for protein. You can see protein in everything now, right? Even water. Rise in sort of small plates or family-style tapas at restaurants. Feels like every restaurant's doing this now. Or for example, a decline in alcohol consumption or interest in alcohol consumption, especially among young people around the world. I think some of this is certainly happening. Producers are listening, but it's hard to disentangle the general trends from a specific GLP-1 impact. I'm grateful for you taking some of the hype out of this and thinking through carefully what the economic implications are of this change and recognizing that there's some real important context that people don't stay on these drugs for long. Or there are certain types of folks who are more likely to use them, and therefore we can't assume that there's this massive wave of change that's going to happen, but that there are some responses. These are important ways of framing this discussion. I have one final question. Based on what you're seeing now with the use of GLP-1s and considering their use over time, what would you say is the key takeaway for policymakers? I think there are a few takeaways. Most importantly, I think policy makers should think about the rapid change in profile of patients who are using this drug. Just because it's beneficial for sick patients doesn't necessarily mean it's going to be equally as beneficial for patients who are less sick. One of the findings in our paper is that as the veteran population that starts to initiate GLP-1s in the more recent years, these patients actually are healthier, so their treatment effects are not quite as strong as those who were initiated in the very early period who in our setting were among the sicker veterans. Policy makers shouldn't extrapolate the potential benefits to a broader population since there's so much demand for this drug, right? This also means that some of the downstream improvements like cost savings or even improved labor outcomes like absenteeism or being able to return to work, while these things might seem logical, it's not fair to assume that it's going to be automatic, especially at a population level. Related to that last point, we should encourage additional research on important socioeconomic outcome that might completely change the calculus of the cost benefit of these drugs, right? So, labor force participation, earnings, use of government transfer programs like disability insurance, even some interesting patterns of household formation and fertility. These are all fascinating and important questions. However, it is imperative to note that GLP-1s already have incredible health benefits for many people. While it's possible that these benefits might spill over to broader societal benefits, these benefits should not be presumed. And at the same time, we shouldn't be holding GLP-1s to a higher standard, say, to reduce healthcare spending or increase earnings just because we know that it does a bunch of wonderful things for a range of conditions. So, maybe it does this and this as well, and suddenly we're less excited if there's no evidence of that and that, right? These things have incredible health benefits. Let's appreciate them for that, and we shouldn't be holding them up to a higher standard just because it appears to do so many wonderful things. BIO Jonathan Zhang is a health economist at the Sanford School of Public Policy at Duke University and the Margolis Institute for Health Policy. He is a Faculty Research Fellow at the National Bureau of Economic Research and an evaluator at the Department of Veterans Affairs. He researches how policy can improve mental health and substance use outcomes using quasi-experimental methods.

Send a textAre veterans gaming the system, or are we trapped in a shallow debate that ignores the law, the medicine, and the lived reality of service? We dig into the difference between media narratives and VA standards with guest Jane Babcock—Army and Army Reserve retiree, former accredited county veteran service officer, and a relentless advocate who's helped file over 1,200 claims.We start by clarifying what disability compensation really is: payment for lost earning capacity tied to service-connected conditions, not a ban on work. From there, we break down presumptive conditions like ALS, the overlooked wartime pension, and why “equipoise” requires raters to side with veterans when evidence is evenly balanced. Jane shares a powerful case where MOS duties and OSHA data linked a young non-smoker's aggressive cancer to specific chemical exposure, proving how targeted research can win tough claims.The conversation then tackles the now-rescinded proposal to rate disabilities in a medicated state. We explain why symptom control isn't cure, how such a rule would punish adherence and invite churn, and how courts have already affirmed ratings must reflect unmedicated baselines. On mental health, we draw the line between stabilization and recovery, outline practical steps to secure DSM-5 diagnoses with Vet Center counseling and VA psychiatry, and stress the power of detailed buddy statements for incidents that never made it into records.We also spotlight the structural mess: VHA, VBA, and cemetery services run on different rails; community and contracted care don't always flow back; and older records can disappear. The fix on the veteran side is ownership—gather civilian files, align diagnoses to rating codes, and work with an accredited VSO who can flag special monthly compensation, aid and attendance, and survivor benefits. Even with OTH discharges, VA adjudication can reopen doors when the facts support service connection.If this conversation helps you or someone you love, share it with a fellow vet, subscribe for more candid guides, and leave a review so others can find it. Your voice keeps this community sharp, informed, and hard to ignore.Support the showVisit my website: https://thehello.llc/THERESACARPENTERRead my writings on my blog: https://www.theresatapestries.com/Listen to other episodes on my podcast: https://storiesofservice.buzzsprout.comWatch episodes of my podcast:https://www.youtube.com/c/TheresaCarpenter76

Law enforcement staffing at federal agencies varied between fiscal years 2020 and 2024. But a new Government Accountability Office report shows the Veterans Health Administration saw a major uptick in law enforcement staffing during that period, going from 4,699 officers in 2020 to 6,281 by the end of 2024. VHA was an outlier as most other federal, state and local law enforcement agencies either had flat workforce totals or saw varying levels of attrition. GAO's report doesn't cover the last year when the Department of Homeland Security recruited a record number of immigration enforcement and Border Patrol agents.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After three decades working to deliver easy, fast and cost-effective patient experiences through technology, Ryan Howells is more optimistic about the future than he's ever been before.At a time when healthcare has been at the center of polarizing and partisan politics, Ryan is focused on an area foundational to digital health that he says draws consensus across party lines: data exchange and interoperability. Freely moving data can unlock innovation in technology, payment models, and regulation to make healthcare work better for everyone, and Ryan is extremely encouraged by the openness to ideas and volume of activity he's seeing from the second Trump Administration in these areas.As Principal at Leavitt Partners since 2015, Ryan collaborates with the private sector, the White House, Congress, HHS, and the VHA to improve health care nationwide. For the past ten years, he has also led the CARIN Alliance, a bi-partisan, multi-sector alliance uniting industry leaders to advance the adoption of consumer-directed exchange across the U.S.In January 2023, Ryan joined Keith Figlioli on the podcast to discuss the myriad of new possibilities emerging in healthcare as a result of better access to data. In this episode, he recounts the progress and obstacles since that conversation, but more importantly, helps unpack the flurry of new activity.Topics Ryan and Keith covered include:ACCESS & TEMPO. These are the latest examples of two new government programs that Ryan believes will remove barriers to innovation. ACCESS is a CMS initiative that now makes it possible for technology companies to bill Medicare directly for digital health services – and get paid only when patients achieve specific, measurable clinical outcomes. Ryan explains how ACCESS is a breakthrough for transparency and has the potential to change contracting for digital health vendors as health system may now ask to share risk. TEMPO is a program from the FDA that complements ACCESS by allowing participating companies to bypass traditional device clearance processes through “enforcement discretion,” provided they share real time data with the FDA. Ryan explains how this oversight lowers cost and complexity for startups and accelerates the path to market for new digital health solutions.Removing administrative roadblocks. In early 2025, Ryan's team at Leavitt Partners published a paper titled, “Kill the Clipboard” that offered recommendations to cut administrative costs, lower the burden on consumers and providers, and modernize the health care data exchange ecosystem. Ryan discussed recommendations like the need for stronger enforcement of information blocking rules and suggestions for the government to change its certification program to focus on APIs, versus functionality of EHRs. He explained how these things would allow health systems to control their own data, build cloud-based workflows, and integrate with payers and innovative companies more easily.Linchpins for data liquidity. Ryan believes that achieving true data liquidity in healthcare requires three foundational elements: a cloud-based data store, an API endpoint, and robust digital identity credentials. With these in place, he says organizations can exchange data securely and efficiently, supporting everything from public health to quality measurement and pharmacy exchange. He says these are the linchpins to finally achieve the data liquidity needed for innovation, interoperability, and improved patient outcomes.To hear Ryan and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for

In this episode, you will learn how Chris Hake thinks about investing profitable in multi-family properties. This was brought to you by VHA, learn more on Value Hound Academy for Real Estate Syndicators | valuehound academy

Friday, August 15th, 2025Today, Governor Gavin Newsom announces a special election in California to fight back against Republican gerrymandering in Texas; a DC man who threw a sandwich at law enforcement was a Department of Justice employee; an inspector general report finds severe shortages at VA hospitals; Kari Lake defends her Voice of America cuts as lawmakers warn her she overstepped; the Fifth Circuit Court of Appeals sides with Black Louisianians by striking down their racists state legislative map; Trump announces his Kennedy Center Honorees and says he might include himself among them; and Allison and Dana read your Good News.Thank You, IQBARText DAILYBEANS to 64000 to get 20% off all IQBAR products, plus FREE shipping. Message and data rates may apply. Guest: John FugelsangTell Me Everything - John Fugelsang, The John Fugelsang PodcastJohn Fugelsang - Substack@johnfugelsang.bsky.social - Bluesky, @JohnFugelsang -TwitterSeparation of Church and Hate by John Fugelsang - Pre-order StoriesCalifornia will move forward with redistricting vote to counter Texas, Newsom says | ABC NewsTrump leaves his mark on the Kennedy Center Honors | POLITICO‘Severe' staff shortages at US veterans' hospitals, watchdog finds | Trump administration | The GuardianKari Lake defends VOA cuts in court after warnings from Capitol Hill | The Washington PostFifth Circuit Sides with Black Louisianians, Strikes Down Racially Discriminatory State Legislative Map | American Civil Liberties UnionFired DOJ employee could face prison for throwing sandwich at officers | The Washington PostGood Trouble “I just received an email from the Center for Reproductive Rights saying that Trump's GSA cut off the connection that let visitors to their website send comments to regulations.gov. The CCR has been asking people to use that link to voice their opposition to the Trump administration's attempt to ban abortion care for veterans and their families, even in cases of rape, incest or medical emergencies.  Wouldn't it be great if Beans listeners made up for the lost  comments by sending thousands today?” Go to regulations.gov and search for Reproductive Health Services or use this link: regulations.gov/commenton/VA-2025-VHA-0073-0002 From The Good Newsregulations.gov/commenton/VA-2025-VHA-0073-0002Lessons from Cats for Surviving Fascism by Stewart Reynolds | Hachette Book GroupErika EvansReminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Our Donation LinksNational Security Counselors - DonateMSW Media, Blue Wave California Victory Fund | ActBlueWhistleblowerAid.org/beansFederal workers - feel free to email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Find Upcoming Actions 50501 Movement, No Kings.org, Indivisible.orgDr. Allison Gill - Substack, BlueSky , TikTok, IG, TwitterDana Goldberg - BlueSky, Twitter, IG, facebook, danagoldberg.comCheck out more from MSW Media - Shows - MSW Media, Cleanup On Aisle 45 pod, The Breakdown | SubstackShare your Good News or Good TroubleMSW Good News and Good TroubleHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?The Daily Beans | SupercastThe Daily Beans & Mueller, She Wrote | PatreonThe Daily Beans | Apple Podcasts

After sharing our despair and anger over US complicity in genocide, we turn to Trump's assault on the VA.  Thanks to the Veterans for Peace convention, we have great and important content.  This week, we hear from Paul Sullivan on VBA, and then Suzanne Gordon on VHA.  Paul discusses the 6 threats to Veterans Benefits, while Suzanne covers the waterfront on the great service VA provides while the government tries to send veterans to a private sector health provider that does not exist.     Jim's number to text is 703 403 6135

Each month, the VA Office of Inspector General publishes highlights of our oversight reports, congressional testimony, and investigative work. In June 2025, the VA OIG published nine reports that included 81 recommendations. Report topics varied from an evaluation of VA's governance of recruitment, relocation, and retention incentives awarded for VHA positions to mental health inspections of the VA Salem Healthcare System in Virginia and the VA Philadelphia Healthcare System in Pennsylvania.  On Capitol Hill, Jennifer McDonald, PhD, director of the Community Care Division for the Office of Audits and Evaluations, testified on June 11 before the House Veterans' Affairs' Subcommittee on Oversight and Investigations. Her testimony focused on the impact of VHA's pause in using its Program Integrity Tool—a system that consolidates community care payment data that is used, in part, to determine if veterans or their private insurance companies should be billed for care that is not connected to injuries or conditions related to their military service. She also highlighted the OIG's work that identified deficiencies in how VA plans, implements, and remediates identified weaknesses in information technology modernization efforts.  VA OIG investigative efforts resulted in the conviction of a chief executive officer of a healthcare software company for a billion-dollar fraud conspiracy. Meanwhile, VA OIG investigative efforts in Louisiana led to the sentencing of two individuals for fraudulently obtaining federal pandemic relief loans.  Related Reports: Recruitment, Relocation, and Retention Incentives for VHA Positions Need Improved Oversight Mental Health Inspection of the VA Salem Healthcare System in Virginia Mental Health Inspection of the VA Philadelphia Healthcare System in Pennsylvania

Each month, the VA Office of Inspector General publishes highlights of our oversight reports, congressional testimony, and investigative work. In May 2025, the VA OIG published 11 reports that included 54 recommendations. Report topics varied from an audit of the VHA's Pain Management, Opioid Safety, and Prescription Drug Monitoring Program to a healthcare inspection to assess allegations of deficiencies in the emergency department care provided to a patient at the Martinsburg VA Medical Center in West Virginia.  On Capitol Hill, Deputy Assistant IG Brent Arronte, in the Office of Audits and Evaluations, testified on May 14 before the House Veterans' Affairs' Subcommittee on Disability Assistance and Memorial Affairs. His testimony focused on the OIG's independent oversight of VA's compensation and benefits programs, specifically how inadequate staff training combined with often unclear and inadequate guidance contribute to incorrect payments being made to veterans.  VA OIG investigative efforts resulted in the sentencing of four defendants for their roles in an $110 million healthcare kickback scheme. Meanwhile, a former nurse at the Michael E. DeBakey VA Medical Center in Houston was indicted for falsely claiming she had checked on a patient who ultimately died. Read the full monthly highlights at: https://www.vaoig.gov/report/monthly-highlights  Related Reports: Better Communication and Oversight Could Improve How the Pain Management, Opioid Safety, and Prescription Drug Monitoring Program Manages Funds Failure to Flag Fiduciaries Who Were Removed Results in Risk to Vulnerable Beneficiaries Deficiencies in Emergency Care for a Female Veteran at Martinsburg VA Medical Center in West Virginia

This Semiannual Report to Congress summarizes the independent oversight efforts of the VA Office of Inspector General (OIG) from October 1, 2024, through March 31, 2025.Visit the VA OIG's website to read the full report. For this six-month period, the VA OIG identified nearly $3.3 billion in monetary impact for a return on investment of $28 for every dollar spent on oversight. These figures do not include the inestimable value of the healthcare oversight work completed to help save the lives of veterans and ensure their access to top-level medical care.During this period, the Office of Investigations opened 256 cases and closed 213 (most opened in prior reporting periods), with efforts leading to 144 arrests. The OIG hotline staff triaged more than 17,000 contacts to help identify wrongdoing and address concerns with VA activities. The related work resulted in 598 administrative sanctions and corrective actions.The Office of Audits and Evaluations (OAE) produced 47 work products, including one VA management advisory memoranda on VA's progress related to reducing overdose deaths. Also included were 16 oversight reports and 30 preaward and postaward contract audits and reviews to help VA obtain fair and reasonable pricing on products and services. OAE reports for the six-month period resulted in 146 recommendations for VA improvements.The Office of Healthcare Inspections (OHI) continued to provide the oversight necessary to assess VHA's delivery of high-quality care and leaders' efforts to build and uphold a culture that prioritizes patient safety. Of the 36 oversight products OHI published in the last six months, 10 were for-cause reports responsive to OIG hotline complaints. In addition to seven national reviews, OHI released 14 healthcare facility inspections, three care-in-the-community inspections, one mental health inspection, and one vet center inspection.The Office of Special Reviews (OSR) conducted 21 investigative interviews and issued one report addressing VA's lapses in oversight of a grantee providing transitional housing services to veterans at risk for homelessness. Also during this period, OSR reviewed 12 allegations of possible whistleblower retaliation involving VA contractor's employees or grantees.

My conversation with Emily begins at 30 mins  Stand Up is a daily podcast that I book,host,edit, post and promote new episodes with brilliant guests every day. Please subscribe now for as little as 5$ and gain access to a community of over 700 awesome, curious, kind, funny, brilliant, generous souls Check out StandUpwithPete.com to learn more Emily Feiner on Blue Sky  Emily on Facebook Emily Feiner, LCSW currently serves as the Chief of Social Work at the VA New Jersey Healthcare System (VANJHCS), a large healthcare system with 2 main campuses and 11Community Based Outpatient Clinics (CBOCs). In that capacity she oversees a staff of over 150 professional social workers and support staff that provide a wide range of social work services in inpatient acute, outpatient and residential settings. Social workers at VANJHCS provide case management, discharge planning, program coordination, psychotherapy and educationservices. Prior to being appointed to her current position, Emily was the Program Manager for the Transition and Care Management (TCM) program at VANJHCS which serves Post 9/11 Veterans, providing case management and other support services. She began her career with the VHA in 2008 when she was hired as a CBOC Social worker at the Hudson Valley VA Health Care System. In that capacity she provided concrete services, case management and crisis intervention to Veterans in a Primary Care clinic. This allowed her to learn the VHA system inside and out rather quickly. Prior to joining VA, Ms. Feiner enjoyed a varied career in Social Work spanning over two decades. She worked with adolescents and young adults in schools and an outpatient clinic, homeless pregnant women in a maternity shelter, and was the Director of an Outpatient Substance Abuse Counseling Center. Ms. Feiner was also an adjunct professor of Social Work at Fordham Graduate School of Social Services where she taught courses in Advanced Practice, Human Behavior and the Social Environment, Substance Abuse Treatment and Clinical Practice seminar. In addition, she also taught in the Human Services program at Westchester Community College. She has maintained a private psychotherapy practice since 1988. Emily has always had a strong commitment to her community and has served on the boards of several community agencies including HeadStart of Rockland and Planned Parenthood Hudson Peconic. She was twice elected to her local Village Board of trustees. Ms. Feiner holds a Bachelor of Arts degree from Hamilton College and a Masters of Social Work from Hunter College of the City University of New York. She has completed the coursework for a PhD in Social Work at New York University. She is the proud mother of two young adults, and enjoys going to hear live music, skiing and hiking in her free time. Emily Feiner, LCSW currently serves as the Chief of Social Work at the VA New Jersey Healthcare System Prior to being appointed to her current position, Emily was the Program Manager for the Transition and Care Management (TCM) program at VANJHCS which serves Post 9/11 Veterans, providing case management and other support services. She began her career with the VHA in 2008 when she was hired as a CBOC Social worker at the Hudson Valley VA Health Care System. In that capacity she provided concrete services, case management and crisis intervention to Veterans in a Primary Care clinic.   She worked with adolescents and young adults in schools and an outpatient clinic, homeless pregnant women in a maternity shelter, and was the Director of an Outpatient Substance Abuse Counseling Center. Ms. Feiner was also an adjunct professor of Social Work at Fordham Graduate School of Social Services where she taught courses in Advanced Practice, Human Behavior and the Social Environment, Substance Abuse Treatment and Clinical Practice seminar. In addition, she also taught in the Human Services program at Westchester Community College. She has maintained a private psychotherapy practice since 1988.   Emily has always had a strong commitment to her community and has served on the boards of several community agencies including HeadStart of Rockland and Planned Parenthood Hudson Peconic. She was twice elected to her local Village Board of trustees. Ms. Feiner holds a Bachelor of Arts degree from Hamilton College and a Masters of Social Work from Hunter College of the City University of New York. She has completed the coursework for a PhD in Social Work at New York University. She is the proud mother of two young adults, and enjoys going to hear live music, skiing and hiking in her free time. Join us Monday's and Thursday's at 8EST for our Bi Weekly Happy Hour Hangout's !  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing Gift a Subscription https://www.patreon.com/PeteDominick/gift

Each month, the VA Office of Inspector General publishes highlights of our investigative work, congressional testimony, and oversight reports. In March 2025, the VA OIG published 17 reports that included 101 recommendations. Report topics varied from a review of VHA and VBA fiscal year 2024 supplemental funding requests and mental healthcare services at a Massachusetts' VA medical center to a review of the veteran self-scheduling process for community care and supply and equipment management deficiencies at a Texas VA medical center. VA OIG investigations led to the sentencing of a pharmacy operator who conspired with various doctors to charge government agencies for medically unnecessary compound prescriptions, pain creams, scar gels, and multivitamins primarily to patients covered under the Office of Workers' Compensation Program. Elsewhere, a government subcontractor was sentenced to 12 months' probation and ordered to pay restitution of more than $493,000 after previously pleading guilty to bank fraud. The company fraudulently obtained a Small Business Administration-backed Paycheck Protection Program loan. The company's owner also agreed to pay more than $1.1 million as part of a civil settlement to resolve his own civil liability.  This latest podcast episode of Veteran Oversight Now highlights the VA OIG's oversight work from March 2025, including four healthcare facility inspections reports on facilities in Massachusetts, Georgia, Virginia, and Washington, DC.  Related Reports: The Causes and Conditions That Led to a $12 Billion Supplemental Funding Request Review of VA's $2.9 Billion Supplemental Funds Request for FY 2024 to Support Veterans' Benefits Payments Inadequate Governance Structure and Identification of Chief Mental Health Officers' Responsibilities  

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Shereef Elnahal, MD, MBA Under Secretary for Health at the Department of Veterans Affairs, joins Eric to discuss the transformative potential of psychedelic-assisted therapies for veterans. The conversation explores the VA's groundbreaking initiatives, including their funding of studies on MDMA and psilocybin, and how these therapies address conditions like PTSD, depression, and addiction.    Dr. Elnahal highlights the VA's role as a leader in mental health research and shares a vision for how these breakthrough therapies could revolutionize care for millions. Learn how veterans themselves have driven this agenda, the promising outcomes from early studies, and the significant hurdles in bringing these therapies to scale.    Tune in for a thought-provoking discussion on the future of mental health treatment for veterans and how the integration of psychedelic-assisted therapies could revolutionize care and improve the quality of life for those who have served.   About Dr. Elnahal Dr. Shereef Elnahal is Under Secretary for Health at the United States Department of Veterans Affairs (VA). He was nominated by President Joseph R. Biden and confirmed by the United States Senate on July 21, 2022. As the Under Secretary for Health, Dr. Elnahal directs a health care system with an annual budget of approximately $102.2 billion, overseeing the delivery of care to more than 9 million enrolled Veterans. The Veterans Health Administration (VHA) is the largest integrated health care system in the United States, providing care at over 1,300 health care facilities, including 171 VA Medical Centers and 1,120 outpatient sites of care of varying complexity (VHA outpatient clinics). VHA is the nation's largest provider of graduate medical education and a major contributor to medical and scientific research. More than 73,000 active volunteers, 127,000 health professions trainees, and more than 362,000 health care professionals and support staff are an integral part of the VHA community.   Dr. Elnahal is physician leader who previously served as President and Chief Executive Officer of University Hospital in Newark, NJ from 2019 through 2022. Dr. Elnahal led University Hospital through the COVID-19 public health emergency. The hospital has served as a model for urban hospital and regional response efforts. In addition to his leadership during the pandemic, Dr. Elnahal oversaw substantial improvements in care quality and patient safety at University Hospital, leading to improvements against national benchmarks. Prior to his time at University Hospital, Elnahal served as New Jersey's 21st Health Commissioner, appointed to the Cabinet post by Governor Phil Murphy and confirmed unanimously by the New Jersey Senate. During his nearly two years as Commissioner, he expanded the New Jersey Health Information Network, an interoperability platform that allows for electronic exchange of patient health information among healthcare providers. He worked closely with New Jersey First Lady Tammy Murphy on her Nurture NJ campaign to help improve infant and maternal health outcomes and reduce health disparities—a mission he continued at University Hospital, with its top tier maternal health services. He also made strides in curbing the opioid epidemic, granting funding to institutions to facilitate data sharing and public health reporting, and marked NJ as the first state in the nation to allow EMS responders to use buprenorphine in the field to prevent withdrawal after naloxone. Dr. Elnahal previously served as VA's Assistant Deputy Under Secretary for Health for Quality, Safety, and Value from 2016 through 2018, overseeing national policies around quality of care for the VHA, and as a White House Fellow in the VA from 2015-16. During that time, he co-founded the VHA Innovation Ecosystem, a program that continues to foster the spread of innovation and best practices that improve Veteran care across the nation. Dr. Elnahal holds an M.D. from Harvard Medical School and an M.B.A. with Distinction from Harvard Business School. Press Release from VA New research would determine the benefit of psychedelics for treating PTSD and depression in Veterans: https://news.va.gov/press-room/to-improve-care-for-veterans-va-to-fund-studies-on-new-therapies-for-treating-mental-health-conditions/   VA Health: https://www.va.gov/health-care/   VA Mental Health Resources: https://www.mentalhealth.va.gov/index.asp   Bright Spots in Healthcare is produced by Bright Spots Ventures Bright Spots Ventures brings healthcare leaders together to share working solution or "bright spots" to common challenges. We build valuable and meaningful relationships through our Bright Spots in Healthcare podcast, webinar series, leadership councils, customized peer events, and sales and go-to-market consulting. We believe that finding a bright spot and cloning it is the most effective strategy to improve healthcare in our lifetime. Visit our website at www.brightspotsinhealthcare.com

As the oldest of 10 children on a farm in Northwest Ohio, David grew up playing and singing gospel, country, and bluegrass. David has a Masters in Theology from Fuller Theological Seminary and earned his Ph.D. from Purdue University in Marriage and Family Therapy. David recently retired from his 40 year career of providing 'Whole Health' education at various Universities and for the VHA. In addition to performing music at White Stallion Ranch and other venues, he consults in the area of Whole Health. Also, he provides guest ranch services at his Ranch in Aravaipa Canyon.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. 

Join us as we welcome Dr. Jonathan Perlin, President and CEO of The Joint Commission, the world-wide leader in accreditation of healthcare institutions. The session explores and provides a personal journey, as a physician and researcher who served as Under Secretary for Health and CEO of the Veterans Health Administration.  After his work with the VHA, Dr. Perlin later became the President of Clinical Operations and Chief Medical Officer with HCA Healthcare. Dr. Perlin provides valuable insights to early careerists entering the world of a profession that balances health equity, environmental sustainability, learning and performance integration. To learn more about Dr. Jonathan Perlin:  https://www.jointcommission.org/who-we-are/joint-commission-officers-group/jonathan-b-perlin/

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM. Leah  discusses military sexual trauma (MST) and the resources available through the VA for veterans who have experienced it. She explains MST as encompassing any unwanted sexual activity during military service, including harassment, assault, or coercion, and notes its lasting impact on individuals. Leah highlights VA-provided support, including fact sheets, MST coordinators, and various therapies like cognitive processing therapy (CPT) and eye movement desensitization and reprocessing (EMDR). She emphasizes the importance of seeking help, acknowledging the challenges of addressing MST within a military culture that often stigmatizes vulnerability. The video also introduces a mobile app and community-based vet center counseling options, urging veterans to take advantage of these resources for their mental and physical well-being.

Drex highlights three critical updates for the healthcare and security community: the FBI's alert on holiday-season email scams, the NIH's new AI tool for clinical trial matching, and a data breach affecting over 2,000 veterans at the VHA. Learn actionable tips to safeguard your organization during this season and stay informed on emerging AI healthcare innovations.Remember, Stay a Little Paranoid Subscribe: This Week Health Twitter: This Week Health LinkedIn: Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.In this episode, Leah discusses Eosinophilic Esophagitis and Gulf War Veterans.

With over nine million veterans enrolled, the Department of Veterans Affairs (VA) is well known for its health care services. However, the VA's support extends beyond medical care, helping veterans navigate life after military service. The VA has undergone a significant transformation since the establishment of the Veterans Experience Office in 2015, focusing on improving veterans' experiences through the use of qualitative and quantitative veteran-customer service data.In this episode, Dr. Carolyn Clancy, Assistant Under Secretary for Health at the VA, shares insights on the organization's evolving approach to health care and the patient experience by discussing:The role of the VA and its evolution in approaches to health care; Transformation through leadership and the creation of the Veterans Experience Office; Holistic attitude to health care through the ‘My life, my story' project; and, Broader applications of VA initiatives in other health care settings Guest Bio: Dr. Clancy serves as the Assistant Under Secretary for Health (AUSH) for Discovery, Education & Affiliate Networks (DEAN), Veterans Health Administration (VHA), effective July 22, 2018. The Office of the DEAN fosters collaboration and knowledge transfer with facility-based educators, researchers, and clinicians within VA, and between VA and its affiliates. Prior to her current position, she served as the Acting Deputy Secretary of the Department of Veterans Affairs, the second-largest Cabinet department, with a $246 billion budget and over 424,000 employees serving in VA medical centers, clinics, benefit offices, and national cemeteries, overseeing the development and implementation of enterprise-wide policies, programs, activities and special interests. She also served as the VHA Executive in Charge, with the authority to perform the functions and duties of the Under Secretary of Health, directing a health care system with a $68 billion annual budget, overseeing the delivery of care to more than 9 million enrolled Veterans. Previously, she served as the Interim Under Secretary for Health from 2014-2015. Dr. Clancy also served as the VHA AUSH for Organizational Excellence, overseeing VHA's performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality. 

Tandi Bagian earned a Bachelor's degree in Engineering from the University of Washington in 1979. She was employed by NASA's Johnson Space Center and served as Lead Instructor for Astronaut Crew Training; Flight Projects Manager for the Space Biomedical Research Institute; and Head of the Crew Interface Analysis Section. This last position involved supervising six Human Factors Laboratories to support NASA's Space Shuttle and Space Station missions. She also was a Principal Science Coordinator for Exploration Human Factors, and in that capacity informed the Agency's Advanced Human Support Technology roadmap in preparation for Mars Exploration mission definition. In 1995, Tandi transferred from NASA to the U.S. Environmental Protection Agency and worked at the EPA's National Vehicle and Fuel Emissions Laboratory in Ann Arbor. Along the way, she earned a Master of Science in Industrial and Operations Engineering from the University of Michigan, Ann Arbor, in 1999. In 2012, Tandi joined the Department of Veteran Affairs as Director, Human Factors Division for the VA National Center for Patient Safety. That team created an award-winning Patient Safety Boot Camp' training for Biomedical Engineers across the entire VHA. With a vision to make sure patient safety is everyone's business', NCPS created strong technical partners across the over 170 VA Medical Centers, as well as with industry partners, to assist Healthcare professionals in providing ‘safer systems, safer care'. With 46 years of Federal Service, Ms. Bagian retired in 2022 and quickly became Associated with the NASA Engineering and Safety Center's Human Factors Technical Discipline Team.  And this is where we met. This HF team is responsible for responding to requests for analysis and review of human factors issues across the NASA Centers and Commercial/International Partners committed to NASA's Moon2Mars mission. Learn more about Tandi: NESC Academy Where to find the hosts: Brian Moon ⁠⁠Brian's website⁠⁠ ⁠⁠Brian's LinkedIn⁠⁠ ⁠⁠Brian's Twitter⁠⁠ Laura Militello ⁠⁠Laura's website⁠⁠ ⁠⁠Laura's LinkedIn⁠⁠ ⁠⁠Laura's Twitter⁠⁠

As the nation's largest integrated health care provider, the Veterans Health Administration prioritizes how technology can address challenges in how it is delivering patient care and securing its infrastructure. Indra Sandal, chief of innovation at VHA in Tampa, Florida, breaks down how more than 300 participants collaborated and addressed challenges in a three-day hackathon. She highlights the takeaways from that hackathon and what it means for veterans. David Rhew, global chief medical officer at Microsoft, also discusses how the organization supported the hackathon and what lessons learned the public-private partnership has for the future of VA health care.

This week Al Montoya, the Veterans Health Administration's (VHA's) acting under secretary for Health for Support, and Spencer Roberts, executive director for Logistics at VHA, join Off the Shelf for a briefing highlighting the VHA's key strategic priorities.Montoya and Roberts outline VHA's strategic efforts in bringing more veterans to the VA and ensuring those veterans receive best in class benefits, care, and support programs.Montoya shares how The Sergeant First Class Heath Robinson Promise to Address Comprehensive Toxics (PACT) Act has increased veteran enrollment by expanding eligibility for VA healthcare for veterans with toxic exposures and veterans of the Vietnam era, Gulf War era, and Post 9/11 erRoga.Roberts discusses VHA's key procurement and logistics developments, including the new MSPV contract vehicle, the focus on supply chain resiliency, and the VHA's recent logistics conference.Montoya also highlights the growing strategic partnership with the Defense Healthcare Agency (DHA) whereby VHA and DHA are sharing resources in markets across the country to deliver care to veterans.Finally, both guests share how, as veterans themselves and customers of the VHA, their personal experiences have helped inform their leadership at the VHA. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week Al Montoya, the Veterans Health Administration's (VHA's) acting under secretary for Health for Support, and Spencer Roberts, executive director for Logistics at VHA, join Off the Shelf for a briefing highlighting the VHA's key strategic priorities. Montoya and Roberts outline VHA's strategic efforts in bringing more veterans to the VA and ensuring those veterans receive best in class benefits, care, and support programs. Montoya shares how The Sergeant First Class Heath Robinson Promise to Address Comprehensive Toxics (PACT) Act has increased veteran enrollment by expanding eligibility for VA healthcare for veterans with toxic exposures and veterans of the Vietnam era, Gulf War era, and Post 9/11 erRoga. Roberts discusses VHA's key procurement and logistics developments, including the new MSPV contract vehicle, the focus on supply chain resiliency, and the VHA's recent logistics conference. Montoya also highlights the growing strategic partnership with the Defense Healthcare Agency (DHA) whereby VHA and DHA are sharing resources in markets across the country to deliver care to veterans. Finally, both guests share how, as veterans themselves and customers of the VHA, their personal experiences have helped inform their leadership at the VHA.

What is the mission of the Strategic Initiatives Lab (Strat Lab) at the Veterans Health Administration (VHA)? How is it using virtual reality and other immersive technologies to change how the department serves veterans? What does the future hold for the VHA's Strat Lab? Join host Michael Keegan as he explores these questions and more with Dr. Anne Bailey, Executive Director, Strategic Initiatives Lab within the Veterans Health Administration. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What is the mission of the Strategic Initiatives Lab (Strat Lab) at the Veterans Health Administration (VHA)? How is it using virtual reality and other immersive technologies to change how the department serves veterans? What does the future hold for the VHA's Strat Lab? Join host Michael Keegan as he explores these questions and more with Dr. Anne Bailey, Executive Director, Strategic Initiatives Lab within the Veterans Health Administration.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Welcome to The Veterans Disability Nexus, where we provide unique insights and expertise on medical evidence related to VA-rated disabilities.Leah Bucholz, a US Army Veteran, Physician Assistant, & former Compensation & Pension Examiner shares her knowledge related to Independent Medical Opinions often referred to as “Nexus Letters” in support of your pursuit of VA Disability every Wednesday at 7 AM.

Show SummaryOn today's episode, we feature a conversation with Navy Veteran Ronald Rutherford, the Lead for the Whole Health Outreach program for the Veterans Health Administration. Whole Health is VA's approach to care that supports the health and well-being of veterans they serve, and focuses on self-care, skill building and support.  About Today's GuestRonald “Ron” Rutherford is the Lead for Whole Health Outreach with the Veterans Health Administration (VHA) Office of Patient Centered Care & Cultural Transformation (OPCC&CT). Based in Pittsburgh, Pennsylvania, he is responsible for liaising with non-governmental and Veteran Service Organizations for the purposes of bringing awareness to VHA's Whole Health offerings for Veterans and their families. Ron joined OPCC&CT in November 2011 as a Field Implementation Consultant for VA medical facilities in Pennsylvania and Delaware. Prior to joining VHA, he served 26 years on active duty in the U.S. Navy and retired as a Senior Chief Hospital Corpsman. As an Independent Duty Hospital Corpsman, Ron served on multiple ships as the primary healthcare provider and healthcare consultant for Occupational and Environmental health programs. During his time in the Navy, he also managed short based and overseas medical facilities, and his last assignment involved managing 11 shipboard medical departments and their staff in Pearl Harbor, Hawaii. Ron has a BSHS in Clinical Health Science (Pre-Physician Assistant Studies) and a MSHS in Healthcare Management from The George Washington University.Links Mentioned In This EpisodeVA Whole Health Program WebsiteWhole Health Program Points of Contact at local VA FacilitiesComplementary and Integrative Health Overview and DescriptionsPsychArmor Resource of the WeekThis week's PsychArmor resource of the week is the PsychArmor course Communicating With Veterans. This course discusses how to communicate effectively with Veterans using communication tools, such as open-ended questions, affirmations, and reflections. You can see find the course here: https://learn.psycharmor.org/courses/communicating-with-veterans This Episode Sponsored By: This episode is sponsored by PsychArmor. PsychArmor is the premier education and learning ecosystems specializing in military culture content PsychArmor offers an. Online e-learning laboratory that is free to individual learners as well as custom training options for organizations. Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

Physician Assistant and prior C&P examiner Leah Bucholz discusses What to Expect in a TMJ Veterans Disability C&P Exam.Leah discusses the Temporal Mandibular Joint Disorder (TMJD), a condition many veterans suffer from, and its relationship with VA disability. TMJD can be related to service either primarily (diagnosed during service and persistent thereafter) or secondarily (related to other conditions like mental health issues or facial injuries). Veterans filing a claim for TMJD will likely undergo a Compensation and Pension (C&P) exam, mostly conducted by contract companies, not the VA. During the exam, dental professionals evaluate the veteran using a Disability Benefits Questionnaire for TMJ, which focuses heavily on the range of motion of the jaw. Ratings for disability due to TMJD can range up to 50% based on several variables, including diet and jaw movement limitations. Leah emphasizes consulting legal professionals to understand the ratings and refers to her other videos for more insights on TMJD.

Physician Assistant and prior C&P examiner Leah Bucholz discusses What to Expect in a Hypothyroidism C&P Exam.Leah explains hypothyroidism and its relevance to VA disability evaluations. Hypothyroidism, often autoimmune (Hashimoto's thyroiditis), is characterized by an underactive thyroid, leading to symptoms like weight gain, fatigue, muscle weakness, menstrual changes, and memory issues. Leah discusses how hypothyroidism can be primary (diagnosed in active duty) or secondary (caused/worsened by another service-connected disorder). She advises veterans on the Compensation and Pension (C&P) exam process following a disability claim, emphasizing the role of the Disability Benefits Questionnaire (DBQ) in documenting symptoms and their impact on daily life and work.

The Veterans Health Administration recently expanded health care benefits to all veterans who served in the Vietnam War, the Gulf War, Iraq, Afghanistan or any other combat zone after 9/11. Behind the scenes, the agency is spearheading many initiatives to further enhance interoperability around its health care ecosystem to better serve veteran patients. Under Secretary for Health Dr. Shereef Elnahal discusses with us at HIMSS in Orlando, Florida, some of the updates around the PACT Act, open APIs and artificial intelligence, plus what programs like Mission Daybreak and innovations like ambient technology have on the transforming health care experience.

On this episode, Dr. Shari Dade is joined by Dr. Christopher Watson. Dr. Watson is a psychologist who began his VA career in 1993, is the VISN 19 Chief Mental Health Officer and has been serving as the Acting Executive Director of the Veterans Crisis Line since late August 2023. He is a member of the American College of Healthcare Executives, Division 18 (Public Practice section) of the American Psychological Association, and the VA Psychology Leaders group. He also regularly provides coaching and mentoring to mental health leaders across the organization, and he has an absolute passion for issues pertaining to diversity, equity, and inclusion. He has particularly demonstrated leadership in addressing systemic racism on the local and national level in VHA, providing numerous presentations and trainings related to diversity and inclusion. Listen in as Dr. Christopher Watson shares the impact insight has on effective leadership, both for the leader and their team.Closed Caption Transcript is available at: https://www.sharedfedtraining.org/Podcasts/TATF_S4E3.pdf ===============================Key Lessons: Being an insightful leader takes work and courage, but it fosters trust, empathy, and authenticity within teams.Leaders who are reflective can operate and communicate with clarity to others.It's important for leaders to use their influence to sponsor the growth and opportunities for others. Having enough insight to realize this does not take from your opportunities is integral.Please check out additional services here: VHA National Center for Organization Development - Home (sharepoint.com)

Physician Assistant and prior C&P examiner Leah Bucholz discusses Frozen Shoulder Syndrome and Veterans' Disability.Leah discusses VA disability ratings for sleep apnea, with a focus on the 50% rating. Although ratings may change and there's been talk of alterations recently, at the time of the video, the ratings have remained stable. Sleep apnea can be classified as obstructive, central, or mixed type. The VA assigns ratings of 0%, 30%, 50%, or 100% to sleep apnea based on severity and required treatments. A 0% rating means the veteran has the disorder but is asymptomatic. A 30% rating indicates daytime sleepiness unimproved by sufficient sleep. A 50% rating is given to those using a breathing device like CPAP or a mouth guard. The 100% rating, which is rare, is assigned for chronic respiratory failure, requiring a tracheostomy or having chloropulmonol. Leah emphasizes the difference between having a breathing device and requiring its use, as this distinction can affect the rating percentage. She advises those navigating the rating system to consult a legal professional or VA-accredited representative for guidance.

Physician Assistant and prior C&P examiner Leah Bucholz discusses Gout and Hypertension in Veterans' Disability.Leah discusses the connection between gout and hypertension, particularly in the context of veterans' disability claims. Gout, an inflammatory arthritis caused by hyperuricemia (excess uric acid in the body), often presents as painful flare-ups, commonly in the big toe. Leah highlights risk factors like being male, obesity, certain health conditions (e.g., hypertension, diabetes), and lifestyle choices (e.g., alcohol consumption, diet high in purines). She explains how hypertension and the use of diuretics for its treatment can be significant risk factors for developing gout. Leah then guides veterans on how gout can be service-connected, either directly or secondarily, due to other conditions or risk factors like obesity or mental health issues with alcohol use. She references several research articles that support the relationship between hypertension and gout, emphasizing the importance of discussing these findings with healthcare providers to explore potential service-related connections.

Physician Assistant and prior C&P examiner Leah Bucholz discusses about Hip Pain Secondary to Knee Injuries in Veterans Disability.Leah discusses the connection between hip pain and knee injuries in the context of VA disability. She emphasizes that hip pain can be service-connected either directly (due to an injury sustained while on active duty) or secondarily, where an existing service-connected condition, like a knee injury, leads to hip problems. Using her own experience with a foot injury leading to hip pain, she illustrates how impairments in one area can impact others. Leah highlights research on how knee osteoarthritis affects hip and ankle mechanics and the significance of the kinetic chain theory, indicating that issues in one joint can influence adjacent joints.

Physician Assistant and prior C&P examiner Leah Bucholz discusses What to Expect in a Hip Pain C&P Exam.Leah explains the process of a compensation and pension (C&P) exam for hip pain. She highlights how hip pain can be service-connected either as a primary condition (like an injury during active duty) or secondarily (due to other service-related conditions). When filing a claim for VA disability, veterans can do it alone or with legal assistance and will receive a packet detailing the exam specifics. The key component of the exam is the Disability Benefit Questionnaire (DBQ), which assesses the veteran's hip condition, including diagnosis, onset, flare-ups, functional loss, and range of motion. Leah emphasizes the importance of understanding the DBQ and range of motion measurements, suggesting veterans view it before the exam to reduce anxiety and better prepare.

Dr. Richard Stone is a retired Army Major General who served as the Deputy Surgeon General of the Army. He had also previously served as the Executive in Charge of the Veterans Health Administration (VHA) with authority to perform the duties of the Under Secretary for Health during the COVID-19 pandemic.    In this role, Dr. Stone became the first official in this position in 30 years to have actual combat experience. He tells us how he needed to become a “calm pillar” during the chaos of COVID and how 70% of veterans have had combat experience, making them a unique group that must be advocated for.   There are a number of challenges in the VHA, including aging facilities that need to be redesigned for modern healthcare. Dr. Stone emphasizes the benefits of recreational therapy as an alternative to pharmaceutical treatment and he shares how much it alleviates the pain of vets when he helps them learn how to surf.      Get your copy of Save Every Life You Can: https://amzn.to/3Bnnnfe    See omnystudio.com/listener for privacy information.